As demonstrated by our findings (Fig. 2A), ECM-modulating genes, such as MMP2 and MMP14, were clearly upregulated in the CAFs,[46] and CAFs were found to secrete PDGFRA and CXCL12, which promote tumor progression,[9] further validate the accuracy of CAF classification. The gene discussed is MMP2; the disease is neoplasm.